Clinical Trials Logo

Clinical Trial Summary

This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.


Clinical Trial Description

PRIMARY OBJECTIVES:

I. To determine the utility of ultrasound elastography in correlation with kidney or liver biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results.

OUTLINE:

Patients undergo ultrasound elastography. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01908166
Study type Interventional
Source Stanford University
Contact
Status Completed
Phase N/A
Start date January 2014
Completion date November 1, 2016

See also
  Status Clinical Trial Phase
Completed NCT01950923 - Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer Phase 1
Withdrawn NCT01688414 - Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer N/A
Recruiting NCT05387863 - Decision Aid (DA) for Renal Patients N/A
Active, not recruiting NCT03819569 - GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses N/A
Recruiting NCT06056505 - Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy N/A
Recruiting NCT01967407 - IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy. Phase 1/Phase 2
Terminated NCT00960063 - A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) Phase 1
Recruiting NCT05890781 - Engineering Immune Organoids to Study Pediatric Cancer N/A
Completed NCT05015179 - Mixed Reality Technology in Laparoscopic Partial Nephrectomy N/A
Completed NCT00019630 - Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Phase 1
Recruiting NCT05728957 - Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors